PHARMACEUTICALS

摘要

Novel oxazino[3,2-a]indole-10-carboxamide derivatives having 5-HT4 receptor antagonist activity and useful in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorders, including irritable bowel syndrome.